Follow
Maurice Whelan
Title
Cited by
Cited by
Year
Adverse outcome pathway (AOP) development I: strategies and principles
DL Villeneuve, D Crump, N Garcia-Reyero, M Hecker, TH Hutchinson, ...
Toxicological Sciences 142 (2), 312-320, 2014
5282014
Systems toxicology: from basic research to risk assessment
SJ Sturla, AR Boobis, RE FitzGerald, J Hoeng, RJ Kavlock, K Schirmer, ...
Chemical research in toxicology 27 (3), 314-329, 2014
3092014
Embedded fibre Bragg grating sensors in advanced composite materials
KSC Kuang, R Kenny, MP Whelan, WJ Cantwell, PR Chalker
Composites Science and Technology 61 (10), 1379-1387, 2001
2922001
Performance assessment of photon migration instruments: the MEDPHOT protocol
A Pifferi, A Torricelli, A Bassi, P Taroni, R Cubeddu, H Wabnitz, ...
Applied optics 44 (11), 2104-2114, 2005
2472005
Incorporating new technologies into toxicity testing and risk assessment: moving from 21st century vision to a data-driven framework
RS Thomas, MA Philbert, SS Auerbach, BA Wetmore, MJ Devito, I Cote, ...
toxicological sciences 136 (1), 4-18, 2013
2272013
Adverse outcome pathway development II: best practices
DL Villeneuve, D Crump, N Garcia-Reyero, M Hecker, TH Hutchinson, ...
Toxicological Sciences 142 (2), 321-330, 2014
2232014
Development of micro-electrode array based tests for neurotoxicity: assessment of interlaboratory reproducibility with neuroactive chemicals
A Novellino, B Scelfo, T Palosaari, A Price, T Sobanski, TJ Shafer, ...
Frontiers in neuroengineering 4, 4, 2011
1622011
Toxicity testing in the 21st century: progress in the past decade and future perspectives
D Krewski, ME Andersen, MG Tyshenko, K Krishnan, T Hartung, ...
Archives of toxicology 94, 1-58, 2020
1522020
How adverse outcome pathways can aid the development and use of computational prediction models for regulatory toxicology
C Wittwehr, H Aladjov, G Ankley, HJ Byrne, J de Knecht, E Heinzle, ...
Toxicological Sciences 155 (2), 326-336, 2017
1432017
Application of micro-electrode arrays (MEAs) as an emerging technology for developmental neurotoxicity: evaluation of domoic acid-induced effects in primary cultures of rat …
HT Hogberg, T Sobanski, A Novellino, M Whelan, DG Weiss, AK Bal-Price
Neurotoxicology 32 (1), 158-168, 2011
1422011
Fowle, r., JR, Wooge, W., Tong, W., & Dix, D.(2013)
R Judson, R Kavlock, M Martin, D Reif, K Houck, T Knudsen, A Richard, ...
Perspectives on validation of high-throughput assays supporting 21st century …, 0
125
Integrative chemical–biological read-across approach for chemical hazard classification
Y Low, A Sedykh, D Fourches, A Golbraikh, M Whelan, I Rusyn, ...
Chemical research in toxicology 26 (8), 1199-1208, 2013
1222013
Development of an adverse outcome pathway from drug-mediated bile salt export pump inhibition to cholestatic liver injury
M Vinken, B Landesmann, M Goumenou, S Vinken, I Shah, H Jaeschke, ...
toxicological sciences 136 (1), 97-106, 2013
1212013
Putative adverse outcome pathways relevant to neurotoxicity
A Bal-Price, KM Crofton, M Sachana, TJ Shafer, M Behl, A Forsby, ...
Critical reviews in toxicology 45 (1), 83-91, 2015
1172015
Perspectives on validation of high-throughput assays supporting 21st century toxicity testing
R Judson, R Kavlock, M Martin, D Reif, K Houck, T Knudsen, A Richard, ...
Altex 30 (1), 51, 2013
1102013
FutureTox II: In vitro Data and In Silico Models for Predictive Toxicology
TB Knudsen, DA Keller, M Sander, EW Carney, NG Doerrer, DL Eaton, ...
Toxicological Sciences 143 (2), 256-267, 2015
1092015
Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization
K Paul Friedman, M Gagne, LH Loo, P Karamertzanis, T Netzeva, ...
Toxicological Sciences 173 (1), 202-225, 2020
972020
Small punch test method assessment for the determination of the residual creep life of service exposed components: outcomes from an interlaboratory exercise
B Ule, T Šuštar, F Dobeš, K Milička, V Bicego, S Tettamanti, K Maile, ...
Nuclear engineering and design 192 (1), 1-11, 1999
961999
Adverse outcome pathways: a concise introduction for toxicologists
M Vinken, D Knapen, L Vergauwen, JG Hengstler, M Angrish, M Whelan
Archives of toxicology 91, 3697-3707, 2017
952017
The adverse outcome pathway approach in nanotoxicology
K Gerloff, B Landesmann, A Worth, S Munn, T Palosaari, M Whelan
Computational Toxicology 1, 3-11, 2017
902017
The system can't perform the operation now. Try again later.
Articles 1–20